XARMONTRA Trademark

Trademark Overview


On Tuesday, March 19, 2013, a trademark application was filed for XARMONTRA with the United States Patent and Trademark Office. The USPTO has given the XARMONTRA trademark a serial number of 85880135. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 6, 2017. This trademark is owned by Eli Lilly and Company. The XARMONTRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders; pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia and dermatological diseases and disorders; pharmaceutical preparations for the treatment of diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders and hormonal diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines; pharmaceutical preparations for the treatment of muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychia...
xarmontra

General Information


Serial Number85880135
Word MarkXARMONTRA
Filing DateTuesday, March 19, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 6, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders; pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia and dermatological diseases and disorders; pharmaceutical preparations for the treatment of diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders and hormonal diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines; pharmaceutical preparations for the treatment of muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders; sleep disorders, urological disorders; antidepressants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 22, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, February 6, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 6, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 31, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 30, 2016EXTENSION 5 GRANTED
Friday, March 25, 2016EXTENSION 5 FILED
Friday, March 25, 2016TEAS EXTENSION RECEIVED
Friday, October 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 1, 2015EXTENSION 4 GRANTED
Tuesday, September 29, 2015EXTENSION 4 FILED
Tuesday, September 29, 2015TEAS EXTENSION RECEIVED
Friday, May 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 28, 2015EXTENSION 3 GRANTED
Saturday, May 16, 2015EXTENSION 3 FILED
Wednesday, May 27, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 15, 2015TEAS EXTENSION RECEIVED
Friday, December 19, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 18, 2014EXTENSION 2 GRANTED
Friday, November 7, 2014EXTENSION 2 FILED
Wednesday, December 17, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 15, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 7, 2014TEAS EXTENSION RECEIVED
Thursday, June 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 10, 2014EXTENSION 1 GRANTED
Tuesday, June 10, 2014EXTENSION 1 FILED
Tuesday, June 10, 2014TEAS EXTENSION RECEIVED
Tuesday, December 31, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2013PUBLISHED FOR OPPOSITION
Wednesday, October 16, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, September 28, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 27, 2013ASSIGNED TO LIE
Monday, September 16, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 16, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 16, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 16, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 14, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 14, 2013NON-FINAL ACTION E-MAILED
Friday, June 14, 2013NON-FINAL ACTION WRITTEN
Thursday, June 13, 2013ASSIGNED TO EXAMINER
Friday, March 22, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 22, 2013NEW APPLICATION ENTERED IN TRAM